SCHEMBL24448850

SCHEMBL24448850

CC(C)(C)c1cc(OCc2ccccc2)ccc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.51
▸ MAOB P27338 9/20 0.49
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ FFAR1 O14842 1/20 0.46
▸ CTSV O60911 1/20 0.45
▸ CTSL P07711 1/20 0.45
▸ MAOA P21397 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17481249 0.88 ALOX5 (0.51) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL21617280 0.81 MAOB (0.53) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL13021506 0.81 MAOB (0.56) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL24449361 0.80 CTSV (0.41) MAOBFFAR1CTSVCTSL
SCHEMBL15817 0.80 ALOX5 (0.61) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL13334863 0.78 NQO1 (0.46) FFAR1MAPTRAB9ASMN1; SMN2PDK2
SCHEMBL6825691 0.78 MAOB (0.52) ALOX5MAOBMAOAMAPTRAB9A
SCHEMBL7975233 0.78 ALOX5 (0.47) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL26424674 0.78 CYP1A2 (0.48) ALOX5MAOBLMNACYP1A2PTGS1
SCHEMBL31166954 0.77 ALOX5 (0.58) ALOX5MAOBLMNACYP1A2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 — — US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 — — US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALOX5 4658/4885MAOB 2905/4885LMNA 2503/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALOX5 4658/4885MAOB 2905/4885LMNA 2503/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A ALOX5 4658/4885MAOB 2905/4885LMNA 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback